MedTrace Logo

Locally Optimised Contouring With AI Technology for Radiotherapy

NCT06546592 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 444

Last updated 2026-01-29

No results posted yet for this study

Summary

LOCATOR is a multicentre phase II randomised clinical trial that is looking at the process of contouring in radiation treatment for breast cancer patients. This study looks at whether contouring aided by artificial intelligence (AI) is comparable in quality to that of contouring done completely manually by a radiation oncologist. We are also looking at whether AI assisted contouring saves radiation oncologists time when compared to fully manual contouring.

LOCATOR uses the LOCATOR software which is an in-house software developed locally and trained on local data.

Conditions

  • Contouring
  • Segmentation
  • Radiation Therapy
  • Artificial Intelligence
  • Deep Learning

Interventions

DEVICE

AI assisted contouring

Initial are generated automatically using software powered by artificial intelligence

Sponsors & Collaborators

  • Royal North Shore Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-02-11
Primary Completion
2026-02-01
Completion
2030-04-30

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06546592 on ClinicalTrials.gov